l-selenomethionine supplementation in children and adolescents with autoimmune thyroiditis: A randomized double-blind placebo-controlled clinical trial.
- 2018-10-10
- RCT
- Journal of clinical pharmacy and therapeutics 44(1)
- Ioannis Kyrgios
- Styliani Giza
- Eleni P Kotanidou
- Angeliki Kleisarchaki
- Vasiliki Rengina Tsinopoulou
- Vasiliki Rengina Tsinopoulou
- Anastasia Papadopoulou
- Anthi-Marina Markantonatou
- Eleni Kanellidou
- Anastasia Giannakou
- Assimina Galli-Tsinopoulou
- PubMed: 30306604
- DOI: 10.1111/jcpt.12765
- High evidence
- Clinical
a statistically significantly higher reduction in anti-Tg levels was observed in the Se group compared to the placebo group (Δ: -70.9 ± 22.1 vs -6.7 ± 60.6 IU/mL, P = 0.021)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 200 μg daily